SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Preventive Visit — Friedrich Nietzsche

PatientFriedrich Nietzsche
Date of birth1989-10-15
IdentifiersMRN HR-NI019-SYN; SSN (made up) 000-19-5523
Document date2026-09-01
AuthorKonrad Ellison-Mbatha, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Periodic adult preventive visit. [S]

History of Present Illness

Mr. Nietzsche is a 36-year-old writer with chronic migraine on galcanezumab, recovering from medication overuse headache after a three-week taper of a butalbital combination, and with pathologic myopia of the right eye and a recent posterior vitreous detachment, who comes for his preventive visit two weeks after his four-week review. He has had headache on 4 days in the past two weeks, 2 of them with migraine features, treated with sumatriptan or naproxen. His second galcanezumab injection, given two weeks ago, caused only mild redness at the site. The floaters in his right eye are fading and he has had no new flashes. He sleeps about five and a half hours and has started the insomnia program. He has not had a tetanus booster for more than ten years and has never been tested for HIV or hepatitis. [S]

ElementDetail
VisitPeriodic adult preventive visit, age 36
Headache4 headache days in two weeks, 2 with migraine features
EyeFloaters fading; no new flashes or shadow
MoodPHQ-2 1
MedicinesGalcanezumab 120 mg monthly; sumatriptan 100 mg or naproxen 500 mg with metoclopramide 10 mg as needed

Health risk assessment. Completed by the patient on paper, in large print, in the waiting room and reviewed with him by Dr. Ellison-Mbatha. [S]

DomainFinding
Self-rated healthFair, and better than at the start of the summer
PsychosocialLives alone and spends most of the day alone, which he prefers for his work; writes to several close friends; small pension
AlcoholA glass of wine a few times a month; AUDIT-C 1 at intake
TobaccoNever
Physical activityWalks five to seven hours a day in the mountains
NutritionSimple meals at fixed times; little meat; fruit and vegetables most days; has kept regular meals since intake
SleepAbout five and a half hours; CBT-I started
Safety at homeFeels safe; no firearms
Sun and altitudeWears sunglasses and a brimmed hat on long walks
Activities of daily livingIndependent
Hearing and visionNo hearing difficulty; reads with the left eye, with contact lenses
Oral healthDental visit last winter

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever, weight loss or night sweats
EyesPositiveFading floaters in the right eye; no new flashes, shadow or loss of vision
Ears, nose, mouth, and throatNegativeNo hearing loss or sore throat
CardiovascularNegativeNo chest pain or palpitations, including after sumatriptan
RespiratoryNegativeNo cough or breathlessness on long climbs
GastrointestinalPositiveOccasional constipation, no worse since starting galcanezumab; no abdominal pain or blood in the stool
GenitourinaryNegativeNo urinary symptoms
MusculoskeletalNegativeNo joint pain
IntegumentaryNegativeNo rash; injection sites healed
NeurologicalPositiveFour headache days in two weeks; no weakness, numbness or new pattern
PsychiatricNegativeMood steady; PHQ-2 1

11 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, one or two tablets as needed for headache, taken on about 16 days a month, up to four tablets a day (prescribed abroad)One or two tablets as needed, about 16 days a month, up to four a dayOral route2025-11-03 to 2026-07-21stoppedS
Ibuprofen 200 mg oral tablet, two tablets as needed for headache on days without the combination tablets, about 4 days a month (over the counter)Two tablets as needed, about 4 days a monthOral route2025-11-03 to 2026-07-21stoppedS
Butalbital 50 mg, acetaminophen 325 mg and caffeine 40 mg oral tablet, scheduled taper: one tablet twice a day for 7 days, then one tablet a day for 7 days, then one tablet every other day for 7 days, then stopScheduled taper over three weeks: twice a day, then once a day, then every other day, then stop; not for extra dosesOral route2026-07-21 to 2026-08-10completedS
Naproxen 500 mg oral tablet, one tablet with food at the start of a migraine attack, may repeat once after 12 hours; no more than two days a weekOne tablet at attack onset, may repeat once after 12 hours; no more than two days a weekOral route2026-07-21activeS
Metoclopramide 10 mg oral tablet, one tablet with the acute medicine when a migraine attack brings nausea or vomiting; no more than two days a weekOne tablet with the acute medicine when nausea is present, no more than once a dayOral route2026-07-21activeS
Galcanezumab 120 mg/mL auto-injector, 240 mg (two injections) under the skin as a first loading dose, then 120 mg once a month, for chronic migraine preventionLoading dose of 240 mg (two injections) on the first day, then 120 mg every four weeksSubcutaneous route2026-07-21activeS
Sumatriptan 100 mg oral tablet, one tablet early in a migraine attack, may repeat once after 2 hours; no more than two days a week and no more than eight days a monthOne tablet at attack onset, may repeat once after 2 hours; up to 200 mg a day, no more than eight days a monthOral route2026-08-18activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-01Body height174cmS
2026-09-01Body weight66.8kgS
2026-09-01Body mass index (BMI) [Ratio]22.1kg/m2S
2026-09-01Systolic blood pressure112mm[Hg]S
2026-09-01Diastolic blood pressure70mm[Hg]S
2026-09-01Heart rate62/minS
2026-09-01Respiratory rate14/minS
2026-09-01Body temperature36.5CelS
2026-09-01Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-01Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S

Physical Exam

Vital signs recorded on 2026-09-01; see the Vital Signs section. [S]

SystemFinding
ConstitutionalLean and well; weight 66.8 kg, BMI 22.1; blood pressure 112/70; pulse 62 and regular
EyesWearing contact lenses; right pupil about 1 mm larger than the left in light and dark, both reacting briskly; no ptosis; eye movements full
NeckNo thyroid enlargement or nodes
CardiovascularRegular rhythm; no murmur
RespiratoryClear to auscultation
AbdomenSoft and non-tender
SkinNo suspicious lesions; injection sites on the abdomen healed
NeurologicalNormal

Problems

ProblemClinical statusVerificationCodeProvenance
Frequent disabling headaches on about 20 days a month, with nausea, vomiting and light sensitivity, mostly right-sided, since childhood and more frequent over the past year, with a combination headache tablet containing butalbital taken on about 16 days a month; under evaluation with a headache diary, MRI, syphilis serology and a headache medicine consultationresolvedconfirmed R51.9S — Synthetic presenting problem anchored to his documented headaches; superseded when the consultation confirmed chronic migraine with medication overuse headache.
Chronic migraine without aura (15 or more headache days a month for more than three months, at least 8 with migraine features); ICHD-3 criteria met in a two-week diary; MRI of the brain normal; synthetic modern diagnosis linked to his documented headaches, which historians interpret differentlyactiveconfirmed G43.709S — Synthetic modern diagnosis made at the consultation; the historical diagnosis is disputed (CLM-0014), so this is not a claim about his real diagnosis.
Medication overuse headache from a butalbital, acetaminophen and caffeine combination on 10 or more days a month for more than three months, with ibuprofen on other days; resolved after a three-week taper and withdrawalactiveconfirmed G44.40S — Synthetic diagnosis made at the consultation, anchored to his documented use of many medicines and sedatives; not a claim about his real medicines.
High myopia in both eyes, much worse in the right eye, since early childhood, with long-standing poor vision in the right eye and unequal pupils; comprehensive eye examination bookedactiveconfirmed H52.13S — Synthetic modern coding of his documented severe myopia.
Pathologic (degenerative) myopia of the right eye with patchy chorioretinal atrophy of the macula, a posterior staphyloma and a tilted optic disc; no choroidal neovascularization on OCT; best corrected vision 20/100 in the right eyeactiveconfirmed H44.2E1S — Synthetic finding of the comprehensive eye examination, anchored to his documented poor right eye and the retrospective reading of it as myopic degeneration; not a claim about his real eyes.
Chronic insomnia, with difficulty falling asleep and early waking, worse on headache nights; no sleep medicine at intakeactiveconfirmed G47.00S — Synthetic sleep problem anchored to his documented severe insomnia; not a claim about his real sleep.
Acute posterior vitreous detachment of the right eye, with flashes and a floater, without a retinal break, detachment or vitreous hemorrhage on dilated examination, in an eye with pathologic myopiaactiveconfirmed H43.811S — Synthetic acute eye problem in a highly myopic eye; not a historical claim.

Assessment and Plan

Personalized prevention plan. A written copy was given to the patient. [S]

ServiceStatusDetail
Blood pressure screeningCompleted today112/70 mmHg
Lipid screening and cardiovascular riskNot indicatedStatin risk assessment is recommended from 40; no risk factors
Diabetes screeningNot indicatedRecommended at 35 to 70 for adults with overweight or obesity; BMI 22.1
Colorectal cancer screeningNot indicatedBegins at 45; no family history known
HIV screeningOrderedOnce for all adults; drawn today
Hepatitis C screeningOrderedOnce for all adults; drawn today
Hepatitis B screeningOrderedTriple panel once for all adults; drawn today before the first vaccine dose
Syphilis testingUp to dateTreponemal antibody and RPR nonreactive at the consultation; repeat only with new exposure
Depression screeningCompleted todayPHQ-2 1
Unhealthy alcohol useUp to dateAUDIT-C 1 at intake
Tobacco useNot indicatedNever used tobacco
Eye examinationUp to dateComprehensive dilated examination six weeks ago; yearly for pathologic myopia
Tetanus, diphtheria, and pertussisCompleted todayTdap today; last booster more than ten years ago
Hepatitis B vaccineCompleted todayFirst of two HepB-CpG doses today; second in one month
Influenza vaccineCompleted todayInactivated vaccine for the coming season
COVID-19 vaccineDeclinedDiscussed as an individual decision; he chose not to have it this season
HPV vaccineNot indicatedRoutine through 26; no new exposure risk at 36
Zoster vaccineNot indicatedRecommended from 50

Immunizations given today: Tdap vaccine; last tetanus booster more than ten years ago; Hepatitis B vaccine (HepB-CpG), first of two doses; Influenza vaccine, inactivated, trivalent, preservative free, for the coming season [S]

Guideline basis: The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (2021); Sexually Transmitted Infections Treatment Guidelines, 2021 (2021); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); USPSTF A and B Recommendations (2026); Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication (2022); Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 (2023); Adult Immunization Schedule by Age (2026)

Follow-up: Eight-week review in two weeks, with the third galcanezumab injection and the repeat dilated eye examination. HIV, hepatitis C and hepatitis B results by phone. Second hepatitis B vaccine dose in one month. Next preventive visit in one year. Next scheduled visit 2026-09-15: eight-week review of prevention: headache days, disability, mood, sleep and the plan ahead. [S]

Advance Care Planning

Voluntary advance care planning discussion of about 16 minutes, with his consent. He named a health care agent, a close friend with whom he corresponds, and a health care proxy form was completed; the agent is recorded in the chart and is not named here. He said that what matters most to him is being able to think clearly, to read and write, and to walk. He chose not to record specific treatment preferences today. The plan will be revisited yearly or after any serious illness. [S]